Group One Trading
CARM

Group One Trading’s Carisma Therapeutics CARM Stock Holding History

Group One Trading’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-163,600
Closed -$479K – 7107
2023
Q4 		$479K Buy
163,600
+5,600
+4% +$16.6K ﹤0.01% 3112
2023
Q3 		$668K Hold
158,000
– – ﹤0.01% 2636
2023
Q2 		$1.39M Sell
158,000
-254,600
-62% -$1.39M ﹤0.01% 2042
2023
Q1 		$1.28M Buy
412,600
+381,490
+1,226% +$3.63M ﹤0.01% 1922
2022
Q4 		$379K Sell
31,110
-5,800
-16% -$60.9K ﹤0.01% 3300
2022
Q3 		$314K Sell
36,910
-2,210
-6% -$30.1K ﹤0.01% 3690
2022
Q2 		$634K Sell
39,120
-810
-2% -$9.27K ﹤0.01% 3207
2022
Q1 		$481K Sell
39,930
-27,125
-40% -$379K ﹤0.01% 3859
2021
Q4 		$1.09M Buy
67,055
+14,475
+28% +$291K ﹤0.01% 3267
2021
Q3 		$834K Buy
52,580
+47,620
+960% +$2.29M ﹤0.01% 3609
2021
Q2 		$458K Sell
4,960
-3,620
-42% -$231K ﹤0.01% 4311
2021
Q1 		$446K Buy
8,580
+8,235
+2,387% +$389K ﹤0.01% 4181
2020
Q4 		$9K Buy
+345
New +$8.75K ﹤0.01% 5813
2020
Q2 		– Sell
-1,445
Closed -$16K – 5803
2020
Q1 		$16K Buy
1,445
+695
+93% +$11.4K ﹤0.01% 4339
2019
Q4 		$16K Buy
750
+335
+81% +$7.7K ﹤0.01% 4431
2019
Q3 		$10K Buy
415
+265
+177% +$6.2K ﹤0.01% 4591
2019
Q2 		$5K Buy
+150
New +$4.49K ﹤0.01% 4593
2019
Q1 		– Sell
-2,215
Closed -$63K – 4834
2018
Q4 		$63K Sell
2,215
-1,430
-39% -$45.6K ﹤0.01% 3422
2018
Q3 		$157K Sell
3,645
-805
-18% -$31.4K ﹤0.01% 3188
2018
Q2 		$174K Buy
+4,450
New +$196K ﹤0.01% 3159

Other funds holding CARM

MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
OP
ORG Partners Roanoke, Indiana $568M AUM 24.16% 1-Year Est. Return

Group One Trading's CARM Position: Q4 2025 in Review

Group One Trading sold out of Carisma Therapeutics (CARM) in Q4 2025, closing a stake of 2,230 shares — an estimated $611 sold.

Group One Trading first reported a position in CARM in Q4 2015 and held it in 31 quarters. The position peaked at $641K in Q4 2021. 7 funds tracked by Wall St. Rank hold CARM as of Q4 2025.

  • Group One Trading reported no remaining Carisma Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 2,230 Carisma Therapeutics shares in Q4 2025, an estimated $611.
  • Group One Trading first reported a position in Carisma Therapeutics in Q4 2015 and held it in 31 quarters.
  • Group One Trading's Carisma Therapeutics position peaked at $641K in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.